Evaluating a Coparenting Breastfeeding Support Intervention
COSI
Evaluating the Effectiveness of a Coparenting Breastfeeding Support Intervention on Exclusive Breastfeeding Rates at 12 Weeks Postpartum
1 other identifier
interventional
428
1 country
1
Brief Summary
The purpose of this trial is to evaluate the effectiveness of a Coparenting Breastfeeding Support Intervention with first time parents on exclusive breastfeeding rates at 12 weeks postpartum. Partner support and the coparenting relationship will also be evaluated.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Feb 2012
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2012
CompletedFirst Submitted
Initial submission to the registry
February 15, 2012
CompletedFirst Posted
Study publicly available on registry
February 20, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2012
CompletedResults Posted
Study results publicly available
January 24, 2014
CompletedJanuary 24, 2014
December 1, 2013
8 months
February 15, 2012
July 4, 2013
December 18, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Exclusive Breastfeeding Rate at 12 Weeks Postpartum
Exclusive breastfeeding will be determined by asking the mother what she has fed her baby in the last 24 hrs and what she usually feeds her baby. This is consistent with the World Health Organizations definition of exclusive breastfeeding and full breastfeeding described by Labbok and Krasovec (1990). This is defined as no food or liquid other than breast milk given to the infant; however, undiluted drops or syrups consisting of vitamins, minerals supplements or medicines are included (Breastfeeding Committee for Canada, 2006; WHO, 2010).
12 weeks postpartum
Secondary Outcomes (9)
Exclusive Breastfeeding
6 weeks
Any Breastfeeding
6 weeks
Any Breastfeeding
12 weeks
Coparenting Relationship
6 weeks
Coparenting Relationship
12 weeks postpartum
- +4 more secondary outcomes
Study Arms (2)
Coparenting Breastfeeding Support Intervention
EXPERIMENTALThe intervention group will receive a in-hospital discussion, a video, a workbook,a breastfeeding booklet, access to a secure study website, two follow-up emails, and one telephone call.
Usual Care Group
NO INTERVENTIONThe usual care group will receive standard postpartum care in the hospital and in the community
Interventions
The intervention group will receive standard care offered to breastfeeding women in the hospital and community with the addition of a multifaceted coparenting breastfeeding support intervention, which will include an in hospital discussion, a video, workbook, breastfeeding booklet, and access to a secure website. Additionally, two follow-up phone calls will be made at 1 and 4 weeks postpartum. This intervention has been designed with coparenting elements and contains extensive breastfeeding information.
Eligibility Criteria
You may qualify if:
- singleton birth (vaginal and cesarean births)
- term infant (37-42 weeks gestation)
- speaks and reads English
- years of age or older
- parents living in the same home, father (the breastfeeding woman's male partner) jointly responsible for the infant.
You may not qualify if:
- sharing a hospital room with a study participant
- infants or maternal medical problems that interfere with breastfeeding (eg. infant with cleft palate or maternal previous breast surgery)
- midwifery patient
- infant not discharged home with mother
- mother is pumping milk but not breastfeeding
- mother does not have access to the internet
- mother does not have a telephone.
- father not available
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
North York General Hospital
North York, Ontario, M2K 1E1, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Jennifer Abbass Dick
- Organization
- University of Toronto
Study Officials
- PRINCIPAL INVESTIGATOR
Cindy-Lee Dennis, PhD
University of Toronto
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor, Lawrence S. Bloomberg Faculty of Nursing
Study Record Dates
First Submitted
February 15, 2012
First Posted
February 20, 2012
Study Start
February 1, 2012
Primary Completion
October 1, 2012
Study Completion
November 1, 2012
Last Updated
January 24, 2014
Results First Posted
January 24, 2014
Record last verified: 2013-12